A detailed history of Smartleaf Asset Management LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 212 shares of VCYT stock, worth $9,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares
212
Previous 49 332.65%
Holding current value
$9,092
Previous $1.08 Million 564.72%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$21.0 - $35.25 $3,423 - $5,745
163 Added 332.65%
212 $7.16 Million
Q2 2024

Aug 13, 2024

BUY
$18.86 - $23.55 $924 - $1,153
49 New
49 $1.08 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $3.07B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.